Upcoming presentations at ESOC 2026

PHRI researchers will be presenting their work at the European Stroke Organisation Conference (ESOC) 2026, taking place May 6-8 in Maastricht, Netherlands. This year’s program features PHRI across oral presentations, posters, scientific sessions, workshops, and panel discussions. 

Research fellow Alexander Benz:

• E-poster: “Bilateral Carotid Filters for Prevention of Stroke Recurrence from Large Vessel Occlusion in Atrial Fibrillation Patients Treated with Oral Anticoagulation- The INTERCEPT trial.“

Investigator Luciana Catanese:

• Presentation: “Stroke Prevention in Women (SERENE): An Individual Patient Data Level Meta-analysis of Four Randomized Controlled Trials on Secondary Stroke Prevention in Women“

Senior scientist Jeff Healey:

• Presentation: “When anticoagulation fails: is LAA closure the answer?” as part of a session on management of recurrent stroke in atrial fibrillation patients on oral anticoagulation.

Scientist Aristeidis Katsanos:

• Presentation: “Superiority and non-inferiority trials – the basics” 

Senior scientist Mike Sharma:

• “Incident Ischaemic Stroke in the Randomised, Placebo- controlled, Event-driven OCEANIC-STROKE Trial of Asundexian for Secondary Stroke Prevention: Severity, Treatment and Outcomes” 
• Net Benefit and Time Course of Benefit of Asundexian for Secondary Stroke Prevention in the Oceanic-stroke Randomised, Placebo-controlled Clinical Trial

Senior scientist Ashkan Shoamanesh:

• Chair for Industry Satellite Symposium – Preventing the Next Stroke: Factor XIa Inhibition from Evidence to Practice” 
  Presentation: “Defining the Role of FXIa Inhibition Through Evidence” 

• E-poster: “Real-world Patient Characteristics and Clinical Outcomes Across Stroke Toast Subtypes: Analysis of a Large Representative Us Electronic Health Record Database”  

• Presentation: “Oral faCtor Eleven A iNhibitor asundexIAn as Novel IC antithrombotic (OCEANIC) – Severity, Treatment and Outcomes” 

• Presentation: “Novel medical secondary prevention strategies for stroke with AF” 

• Workshop: “Lessons Learned in Leadership in Conducting Clinical Trials” 

• Paper Poster Presentation: “Intracranial Haemorrhage in Patients with Non-cardioembolic Ischaemic Stroke or High-risk TIA: Insights from the Oceanic-stroke Randomised Trial of Asundexian for Secondary Stroke Prevention” 
• Paper Poster Presentation: “Predictors of Recurrent Ischaemic Stroke in Patients with Non-cardioembolic Ischaemic Stroke: Insights from the Oceanic-stroke Randomised Trial of Asundexian for Secondary Stroke Prevention.”